Status:
COMPLETED
The Efficacy of Oral Antiseptics Against COVID-19
Lead Sponsor:
Ataturk University
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
In a study conducted on 75 COVID-19 patients, the effect of SARS-CoV-2 on viral load was investigated as a result of the use of hypochlorous acid and povidone-iodine as an oral antiseptic.
Detailed Description
Before and 30 minutes after rinsing with mouth antiseptics, the participants were asked to rinse the mouth and throat for 30 seconds with 0.9% isotonic saline. The sample was sputtered into a sterile ...
Eligibility Criteria
Inclusion
- Positive SARS-CoV-2 RT-PCR result,
- Adult hospitalized patient,
- The participants have the physical and psychological ability to follow the instructions in the study.
Exclusion
- Patients intubated and supported by a mechanical respirator,
- Severe acute or chronic medical or psychiatric condition,
- History of significant adverse effects following use of oral hygiene products such as toothpaste and mouth rinses,
- Active uncontrolled thyroid disease,
- Developmental/cognitive disability,
- Pregnancy,
- Undergoing radioactive iodine therapy.
Key Trial Info
Start Date :
September 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 7 2021
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT05214196
Start Date
September 1 2021
End Date
December 7 2021
Last Update
February 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Atatürk University Faculty of Dentistry
Erzurum, Turkey (Türkiye), 25240